Gregory Adams, PhDChief Scientific Officer at Elucida OncologySpeaker
Agenda Sessions
Co-Chairs’ Remarks
, 2:10pmView SessionFirst in Human Studies with ELU001, an anti-Folate Receptor Alpha Targeted C'Dot Drug Conjugate
, 4:15pmView Session